Skip to main content
Craig Hendrix, MD, Infectious Disease, Baltimore, MD

CraigWalterHendrixMD

Infectious Disease • Baltimore, MD

HIV/AIDS Medicine

Wellcome Professor and Director, Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Hendrix is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hendrix's full profile

Already have an account?

Summary

  • Dr. Craig Hendrix is a clinical pharmacologist and infectious disease specialist at Johns Hopkins University. He received his medical degree from Georgetown University School of Medicine and has been in practice 33 years. He specializes in clinical pharmacology of drug development for HIV prevention.

Education & Training

  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineFellowship, Clinical Pharmacology, 1987 - 1989
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 1986 - 1989
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1984 - 1986
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1984
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyS.B., Applied Biology, 1974 - 1978

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1994 - 2024
  • PA State Medical License
    PA State Medical License 1990 - 1994
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • William F. Abrams Award American Socity of Clinical Pharmacology & Therapeutics (ASCPT) – Food and Drug Administration (FDA) William F. Abrams Award 2019, 2019
  • Distinguished Investigator Award American College of Clinical Pharmacology, 2018
  • Award in Excellence PhRMA Foundation, 2017
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Rectal Douching Practices Associated with Anal Intercourse: Implications for the Development of a Behaviorally Congruent HIV-Prevention Rectal Microbicide Douche  
    Craig W Hendrix, Edward J Fuchs, AIDS and Behavior
  • Safety, Tolerability, and Pharmacokinetics of Long-Acting Injectable Cabotegravir in Low-Risk HIV-Uninfected Individuals: HPTN 077, a Phase 2a Randomized Controlled Trial  
    Susan H Eshleman, Joseph J Eron, Raphael J Landovitz, Myron S Cohen, Jeremy Sugarman, Mark A Marzinke, Craig W Hendrix, PLoS One
  • Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women  
    Craig W Hendrix, Robert A Salata, Mark A Marzinke, Craig J Hoesley, Ian McGowan, Clinical Infectious Diseases
  • Join now to see all

Books/Book Chapters

  • Novel Pharmacokinetic Methods for Developing HIV Chemoprevention Strategies. 
    Hendrix CW2005
  • Strategies for the Management of HIV/HCV Co-infection. 
    Chapter: Hepatotoxicity of antiretroviral therapy and drug-drug interactions with antiviral therapies for hepatitis C infection. 
    Hendrix CW, Sulkowski MSSeacaucus: Projects in Knowledge2002
  • Protecting Data Privacy in Health Services Research. 
    Chapter: Institutional Review Boards and Health Services Research Data Privacy. A Workshop Summary. 
    Committee on the role of institutional review boards in health services research data privacy protection.Institute of Medicine, National Academy Press, Washington, DC2000
  • Join now to see all

Lectures

  • Scientific Misconduct. 
    FDA Office of Criminal Investigations. Charleston, SC. - 6/18/2013
  • Making sense out of oral and topical PrEP trials: Using little studies to understand big studies. 
    Annual Meeting of HIV Prevention Trials Network, Washington, DC. - 5/6/2013
  • Pharmacological Challenges for Next Generation PrEP. 
    14th International Workshop on Clinical Pharmacology of HIV Therapy, Amsterdam, Netherlands. - 4/23/2013
  • Join now to see all

Other

  • Rectal Microbicide Development: Measuring Gel & Virus Distribution. 
    Hendrix CW
    Web-Cast Teleconference, Invited Talk, International Rectal Microbicides Working Group. - 3/1/2006
  • Platelet glycoprotein IIIa PIA polymorphism and effects of aspirin on thrombin generation. 
    Bray PF, Goldschmidt-Clermont P, Furman MI, Michelson AD, Barnard MR, Mascelli MA, Hendrix C, Coleman L, Hamlington J, Kickler T, Christie DJ, Kundu S
    Letter. Response Circulation. - 2/13/2001
  • AIDS in the Public Eye: AIDS Fatigue or Healthy Maturation. 
    Hendrix CW
    Lutheran AIDS Network Newsletter - 1/1/2000
  • Join now to see all

Press Mentions

  • Cisgender Women’s Rectal Tissue May Be More Vulnerable to HIV Than Men’s
    Cisgender Women’s Rectal Tissue May Be More Vulnerable to HIV Than Men’sJuly 15th, 2021
  • Johns Hopkins Names First Black Female Chair to Lead School Department
    Johns Hopkins Names First Black Female Chair to Lead School DepartmentSeptember 6th, 2020
  • Namandjé Bumpus Makes History with New Department Chair Role
    Namandjé Bumpus Makes History with New Department Chair RoleJune 23rd, 2020
  • Join now to see all

Grant Support

  • Exploratory Pharmcokinetics Of UC781 &Tenofovir Vaginal Microbicide Gel V FILMNational Institute Of Allergy And Infectious Diseases2010–2011
  • Phase I Rectally-Formulated Rectal MicrobicideNational Institute Of Allergy And Infectious Diseases2009
  • Interaction Between AMD 11070 And Sustrates Of CYP3A4 And 2D6 EnzymesNational Center For Research Resources2007
  • Methadone Qd With FosamprenavirNational Center For Research Resources2006–2007
  • A Potential Rectal Microbicide Vehicle And Semen SurrogateNational Center For Research Resources2005–2007
  • P5 - Effect Of Rectal Preparatory Enemas On Microbicide Distribution, TOXNational Institute Of Allergy And Infectious Diseases2006
  • Collection Of Biological Samples For LAB Assay DevelopmentNational Center For Research Resources2004–2006
  • MALE Genital TractNational Center For Research Resources2005
  • Sampling Frequency Limitations Of Antiretroviral DrugsNational Center For Research Resources2004–2005
  • Compare The Spread And Distribution Of A Potential Rectal MicrobicideNational Center For Research Resources2004–2005
  • Candida Ecology In The Intensive Care UnitNational Center For Research Resources2004
  • Antiretroviral Semen Analysis Feasibility StudyNational Center For Research Resources2004
  • Pharmacology Of Antiretroviral Drugs In Genital TractNational Institute Of Allergy And Infectious Diseases2000–2004
  • S1153 Action With Protease Inhibitors And 3tc/Zvd/D4tNational Center For Research Resources2000–2002
  • Pharmacokinetics Of IV AMD 3100 In Normal VolunteersNational Center For Research Resources2000–2002
  • P24 Antigen Levels--Antiretroviral Drug StudiesNational Center For Research Resources2000–2002
  • Ocular Activity Of Oral 12263w94 In AIDS CMV RetinitisNational Center For Research Resources2000–2002
  • Efavirenz In Combo With Ritonavir/Saquinavir In HIVNational Center For Research Resources2000–2002
  • Accutane/Oral Contraceptives In Women With Nodular AcneNational Center For Research Resources2000–2002
  • Pharmacokinetics/Safety Of Lobucavir In Subjects With Hepatic ImpairmentNational Center For Research Resources1998–2002
  • Pharmacokinetics And Safety Of Lobucavir In Subjects With Hepatic ImpairmentNational Center For Research Resources1998–2002
  • Trial To Evaluate Ocular (INTRAVITREAL) Penetration Of 1263w94National Center For Research Resources1999
  • Sp-303--Double-Blind, Randomized, Placebo-Controlled StudyNational Center For Research Resources1999
  • Safety, Pharmacokinetics, &Tolerability Of IV Administered AMD 3100National Center For Research Resources1999
  • Potential Interaction Between S1153 &Protease InhibitorsNational Center For Research Resources1999
  • Pharmacokinetic Interactions Of Ritonavir, Saquinavir &Efavirenz-Open LabelNational Center For Research Resources1999

External Links

Dr. Craig Hendrix, Dr. Craig Hendrix, MD, Dr. C Hendrix, Dr. Craig Walter Hendrix